[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

EMEA (Europe, Middle East and Africa) Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Report 2017

December 2017 | 113 pages | ID: E41A83319ADEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Benign Prostatic Hyperplasia (BPH) Treatment Devices for these regions, from 2012 to 2022 (forecast)
  • Europe: Germany, France, UK, Russia, Italy and Benelux;
  • Middle East: Saudi Arabia, Israel, UAE and Iran;
  • Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices market competition by top manufacturers/players, with Benign Prostatic Hyperplasia (BPH) Treatment Devices sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Endo International (US)
  • Karl Storz (Germany)
  • Medtronic (US)
  • Siemens (Germany)
  • Lumenis (Israel)
  • Olympus (Japan)
  • Urologix (US)
  • NeoTract (US)
  • Boston Scientific (US)
  • Urotech (Germany)
  • Toshiba (Japan)
  • Baxter International (US)
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Laser Based Procedure
  • Other Energy Based Procedure
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
EMEA (Europe, Middle East and Africa) Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Report 2017

1 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES OVERVIEW

1.1 Product Overview and Scope of Benign Prostatic Hyperplasia (BPH) Treatment Devices
1.2 Classification of Benign Prostatic Hyperplasia (BPH) Treatment Devices
  1.2.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Laser Based Procedure
  1.2.4 Other Energy Based Procedure
1.3 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market by Application/End Users
  1.3.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospitals
  1.3.3 Ambulatory Surgical Centers
  1.3.4 Specialty Clinics
  1.3.5 Other
1.4 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market by Region
  1.4.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Benign Prostatic Hyperplasia (BPH) Treatment Devices (2012-2022)
  1.5.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2022)

2 EMEA BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Competition by Players/Manufacturers
  2.1.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Players (2012-2017)
2.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume and Value) by Type/Product Category
  2.2.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Type (2012-2017)
2.3 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume) by Application
2.4 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume and Value) by Region
  2.4.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price by Region (2012-2017)

3 EUROPE BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
  3.1.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
3.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Type
3.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Application
3.4 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume by Countries (2012-2017)
  3.4.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries (2012-2017)
  3.4.3 Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2017)
  3.4.4 France Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2017)
  3.4.5 UK Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2017)
  3.4.6 Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2017)
  3.4.7 Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2017)

4 MIDDLE EAST BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
  4.1.1 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
4.2 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Type
4.3 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Application
4.4 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2017)
  4.4.4 Israel Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2017)
  4.4.5 UAE Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2017)
  4.4.6 Iran Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2017)

5 AFRICA BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
  5.1.1 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
5.2 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Type
5.3 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Application
5.4 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume by Countries (2012-2017)
  5.4.2 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries (2012-2017)
  5.4.3 South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2017)

6 EMEA BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Endo International (US)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Karl Storz (Germany)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Medtronic (US)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Siemens (Germany)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Lumenis (Israel)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Olympus (Japan)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Urologix (US)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 NeoTract (US)
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Boston Scientific (US)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Urotech (Germany)
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Toshiba (Japan)
6.12 Baxter International (US)

7 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MANUFACTURING COST ANALYSIS

7.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET FORECAST (2017-2022)

11.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Price and Trend Forecast (2017-2022)
11.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Type (2017-2022)
11.7 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (Product Category) in 2016
Figure Laser Based Procedure Product Picture
Figure Other Energy Based Procedure Product Picture
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Ambulatory Surgical Centers Examples
Table Key Downstream Customer in Ambulatory Surgical Centers
Figure Specialty Clinics Examples
Table Key Downstream Customer in Specialty Clinics
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Million USD) by Region (2012-2022)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) Status and Forecast by Countries
Figure Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2022)
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Players (2012-2017)
Figure 2016 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Players
Figure 2017 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Players
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Players (2012-2017)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Players (2012-2017)
Table 2016 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Players
Table 2017 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Players
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Type (2012-2017)
Figure Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2012-2017)
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2012-2017)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type in 2016
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Application (2012-2017)
Figure Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application (2012-2017)
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application in 2016
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Region (2012-2017)
Figure Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Region (2012-2017)
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in 2016
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Region (2012-2017)
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Regions in 2016
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Type (2012-2017)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Type (2012-2017)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Type in 2016
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Application (2012-2017)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Application (2012-2017)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Application in 2016
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Countries (2012-2017)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries (2012-2017)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries (2012-2017)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries in 2016
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Countries (2012-2017)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2012-2017)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2012-2017)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries in 2016
Figure Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure France Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure UK Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Type (2012-2017)
Table Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Type (2012-2017)
Figure Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Type (2012-2017)
Table Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Applications (2012-2017)
Table Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Applications (2012-2017)
Figure Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application in 2016
Table Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Countries in 2016
Table Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Countries (2012-2017)
Table Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2012-2017)
Figure Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2012-2017)
Figure Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries in 2016
Figure Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Type (2012-2017)
Table Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2012-2017)
Figure Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2012-2017)
Figure Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type in 2016
Table Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Application (2012-2017)
Table Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2012-2017)
Figure Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2012-2017)
Table Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Countries (2012-2017)
Table Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries (2012-2017)
Figure Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries (2012-2017)
Figure Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries in 2016
Table Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Countries (2012-2017)
Table Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2012-2017)
Figure Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2012-2017)
Figure Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries in 2016
Figure South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in EMEA (2012-2017)
Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in EMEA (2012-2017)
Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in EMEA (2012-2017)
Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in EMEA (2012-2017)
Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in EMEA (2012-2017)
Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in EMEA (2012-2017)
Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in EMEA (2012-2017)
Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in EMEA (2012-2017)
Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in EMEA (2012-2017)
Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in EMEA (2012-2017)
Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in EMEA (2012-2017)
Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in EMEA (2012-2017)
Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in EMEA (2012-2017)
Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in EMEA (2012-2017)
Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in EMEA (2012-2017)
Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in EMEA (2012-2017)
Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in EMEA (2012-2017)
Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in EMEA (2012-2017)
Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in EMEA (2012-2017)
Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in EMEA (2012-2017)
Table Toshiba (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Baxter International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure Benign Prostatic Hyperplasia (BPH) Treatment Devices Industrial Chain Analysis
Table Raw Materials Sources of Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Manufacturers in 2016
Table Major Buyers of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Table Distributors/Traders List
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Region (2017-2022)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Region (2017-2022)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Countries (2017-2022)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Countries (2017-2022)
Table Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Type (2017-2022)
Table EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories